Clinical Trial: Clinical Study on the Efficacy and Safety of Hydrocodone Bitartrate Sustained-Release Tablets Combined with Tapentadol in the Treatment of Moderate to Severe Cancer Pain (China)

Posted On: 2026-11-02

China, Nov. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical Study on the Efficacy and Safety of Hydrocodone Bitartrate Sustained-Release Tablets Combined with Tapentadol in the Treatment of Moderate to Severe Cancer Pain'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135638

Registration Time: 2026/10/31

Type: Interventional study

Primary Sponsor: Huadong Hospital Affiliated to Fudan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344761

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Clinical Study on the Efficacy and Safety of Hydrocodone Bitartrate Sustained-Release Tablets Combined with Tapentadol in the Treatment of Moderate to Severe Cancer Pain (China)